Checkpoint Genes at the Cancer Side of the Immunological Synapse in Bladder Cancer
Immune checkpoint inhibitors have revolutionized cancer therapy, but not all cancers respond to the currently available drugs, and even within cancers considered responsive to such modality, response rates range between 15 and 40%, depending on the cancer type, the line of treatment, and yet unknown...
| المؤلفون الرئيسيون: | , , , , , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
Elsevier
2020-02-01
|
| سلاسل: | Translational Oncology |
| الوصول للمادة أونلاين: | http://www.sciencedirect.com/science/article/pii/S1936523319303389 |